Article · Volume 3, Issue 2 · pp. 196–199

Ethionamide-induced gynecomastia

Ramakant Dixit¹, Jacob George¹, Arun K. Sharma², Naveen chhabra², Suresh K. Jangir¹, Vikas Mishra¹

1. ¹Departments of Respiratory Medicine, College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.
2. ²Pharmacology and Experimental Therapeutics, J. L. N. Medical College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.

The full text of this article is available as a PDF. Open the PDF.